Volume 2 - Issue 1 - January 2002
Column
Feature Interview
05/03/2008
Paceart has been a pioneer in the concept and application of computerized pacemaker follow-up, both for clinical and transtelephonic monitoring. They are the established market leader with over 900 pacemaker and arrhythmia centers utilizing...
Paceart has been a pioneer in the concept and application of computerized pacemaker follow-up, both for clinical and transtelephonic monitoring. They are the established market leader with over 900 pacemaker and arrhythmia centers utilizing...
Paceart has been a pioneer in...
05/03/2008
EP Lab Digest
Editorial
05/03/2008
The positive results of this trial will expand device implantations to patients who meet the MADIT II studies entry criteria.
The positive results of this trial will expand device implantations to patients who meet the MADIT II studies entry criteria.
The positive results of this...
05/03/2008
EP Lab Digest
Spotlight Interview
05/03/2008
EMH Regional Healthcare System (formerly Elyria Memorial Hospital), which was founded in 1915, is a 438-bed, two-hospital system with campuses in Elyria and Amherst, Ohio.
EMH Regional Healthcare System (formerly Elyria Memorial Hospital), which was founded in 1915, is a 438-bed, two-hospital system with campuses in Elyria and Amherst, Ohio.
EMH Regional Healthcare System...
05/03/2008
EP Lab Digest
Feature Interview
05/03/2008
Electrophysiology is the most rapidly growing field in cardiology. It is a very exciting time to be in electrophysiology. In particular, we are seeing an expansion in the applications and indications of implantable devices,
Electrophysiology is the most rapidly growing field in cardiology. It is a very exciting time to be in electrophysiology. In particular, we are seeing an expansion in the applications and indications of implantable devices,
Electrophysiology is the most...
05/03/2008
EP Lab Digest
Feature
Feature Story
05/03/2008
Before FDA approval of the automatic implantable cardioverter-defibrillator, the primary treatment for life-threatening ventricular tachycardia was drug therapy. Unfortunately, many of the antiarrhythmic drugs also had a proarrhythmic side...
Before FDA approval of the automatic implantable cardioverter-defibrillator, the primary treatment for life-threatening ventricular tachycardia was drug therapy. Unfortunately, many of the antiarrhythmic drugs also had a proarrhythmic side...
Before FDA approval of the...
05/03/2008
EP Lab Digest
Feature Story
05/03/2008
Although neurocardiogenic syncope is not yet completely understood, it seems to occur when a person is standing upright for a prolonged period of time, earning the nickname "church syncope". Knowing the circumstances surrounding each syncopal...
Although neurocardiogenic syncope is not yet completely understood, it seems to occur when a person is standing upright for a prolonged period of time, earning the nickname "church syncope". Knowing the circumstances surrounding each syncopal...
Although neurocardiogenic...
05/03/2008
EP Lab Digest
Feature Story
05/03/2008
The South Atlantic Society of Electrophysiology for Allied Professionals (SASEAP) workshop took place in Myrtle Beach, South Carolina.
The South Atlantic Society of Electrophysiology for Allied Professionals (SASEAP) workshop took place in Myrtle Beach, South Carolina.
The South Atlantic Society of...
05/03/2008
EP Lab Digest
Department
EP 101
05/03/2008
The use of drugs to favorably alter heart rhythm began in 1914 with quinidine, whose antiarrhythmic actions were found by accident. Since that time, the number and complexity of drug categories has evolved to the extent that we have come...
The use of drugs to favorably alter heart rhythm began in 1914 with quinidine, whose antiarrhythmic actions were found by accident. Since that time, the number and complexity of drug categories has evolved to the extent that we have come...
The use of drugs to favorably...
05/03/2008
EP Lab Digest
